Methylpiperidino pyrazole
CAS No. 289726-02-9
Methylpiperidino pyrazole ( —— )
产品货号. M27481 CAS No. 289726-02-9
甲基哌啶基吡唑是一种 ERα 抑制剂,可以阻止 BPS 诱导的 Rb 磷酸化和细胞周期进程。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥478 | 有现货 |
|
| 5MG | ¥697 | 有现货 |
|
| 10MG | ¥1288 | 有现货 |
|
| 25MG | ¥2827 | 有现货 |
|
| 50MG | ¥5289 | 有现货 |
|
| 100MG | ¥7930 | 有现货 |
|
| 200MG | ¥11899 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Methylpiperidino pyrazole
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述甲基哌啶基吡唑是一种 ERα 抑制剂,可以阻止 BPS 诱导的 Rb 磷酸化和细胞周期进程。
-
产品描述Methylpiperidino pyrazole is an ERα inhibitor and can prevent the BPS-induced Rb phosphorylation and cell cycle progression.
-
体外实验MPP (1, 5, 10, 25, 50 and 100 μM; 24 h) decreases cell viability with an IC50 value of 20.01 μM in RL95-2 cells.MPP dihydrochloride shows antiproliferative activity at a concentration of 10 μM inRL95-2 cells.MPP dihydrochloride (20 μM; 24 h) reduces the phosphorylation of ERα, while it does not alter the phosphorylation of Akt. MPP dihydrochloride reduces the ratio of p-ERα/ERα.Cell Viability Assay Cell Line:RL95-2 endometrium cancer cells Concentration:1, 5, 10, 25, 50 and 100 μM Incubation Time:24 hours Result:The treatment with 25 μM, 50 μM and 100 μM for 24 h decreased cell viability significantly. However, cell viability was not significantly changed by MPP dihydrochloride at concentration below 25 μM.Cell Proliferation Assay Cell Line:RL95-2 cell Concentration:10, 15, 20 and 25 μM Incubation Time:72 hours Result:Showed antiproliferative activity at a concentration of 10 μM.Western Blot Analysis Cell Line:RL95-2 cell line Concentration:20 μM Incubation Time:24 hours Result:Reduced the phosphorylation of ERα, while it did not alter the phosphorylation of Akt. Reduced the ratio of p-ERα/ERα compared to the control group.
-
体内实验MPP (Low dose 20 μg/kg body weight or high dose 200 μg/kg body weight) leads to a dose-dependent attenuation of percent prepulse inhibition (PPI). Animal Model:Male C57BL/6N mice at the age of 9-10 weeksDosage:Low dose (20 μg/kg body weight) or high dose (200 μg/kg body weight) Administration:Administered subcutaneously (s.c.) injected; injection volume of 5 mL/kg; 60 min before PPI testing Result:Led to a dose-dependent attenuation of percent PPI. Pretreatment with 200 μg/kg reduced the mean percent PPI scores by ~30%.
-
同义词——
-
通路Endocrinology/Hormones
-
靶点Estrogen Receptor/ERR
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number289726-02-9
-
分子量469.57
-
分子式C29H31N3O3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCc1c(-c(cc2)ccc2OCCN2CCCCC2)n(-c(cc2)ccc2O)nc1-c(cc1)ccc1O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Robinson DM, Keating GM. Colesevelam: a review of its use in hypercholesterolemia. Am J Cardiovasc Drugs. 2007;7(6):453-65.
产品手册
关联产品
-
Anthraquinone
Anthraquinone 被用作染料形成的前体。
-
Prinaberel
Prinaberel (ERB-041) 是一种有效的选择性雌激素受体 β (ERβ) 激动剂,对人,大鼠和小鼠 ERβ 的 IC50 分别为 5.4、3.1 和 3.7 nM。 Prinaberel对 ERβ 的选择性是 ERα 的 200 倍以上。Prinaberel是有效的皮肤癌化学预防剂,可通过抑制 WNT/β-catenin 信号通路发挥作用。Prinaberel 诱导卵巢癌细胞凋亡 (apoptosis)。
-
Astragaloside IV
Astragaloside IV 是从黄芪中分到的皂苷类物质,能够抑制 ERK1/2 和 JNK 的激活,在乳腺癌细胞 MDA-MB-231 中,能够下调 (MMP)-2,(MMP)-9 的信号通路。
021-51111890
购物车()
sales@molnova.cn

